PSN
pseudoephedrine HCl 60 MG / pyrilamine maleate 30 MG Oral Tablet
Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Histanaz Tablet
RxNorm Crosswalk NDC 29978-129
View RxNorm Concepts, RxCUIs, and Term Type mappings for this NDC
RxNorm Mapping Clinical Concepts
The product Histanaz (NDC 29978-129) is cross-mapped to the RxNorm terminology system to ensure clinical interoperability. This formulation is linked to a unique clinical concept (RxCUI 2727351). By anchoring Capital Pharmaceutical, Llc's product data to these standardized identifiers, healthcare systems can maintain accurate medication records, safely automate e-prescribing, and streamline pharmacy workflows.
The following clinical concept cards detail the semantic term types (TTY), prescribable names, and synonymous clinical strings as defined by the National Library of Medicine (NLM).
SCD
Featured Concept
pseudoephedrine hydrochloride 60 MG / pyrilamine maleate 30 MG Oral Tablet
(RxCUI 2727351)
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
Understanding RxNorm Mapping for Histanaz
RxNorm is a normalized naming system developed by the National Library of Medicine (NLM) to bridge the gap between different drug terminologies. By mapping NDC 29978-129 to RxCUI 2727351, this page provides the standardized "source of truth" required for hospital systems, e-prescribing software, and pharmacy benefit managers (PBMs) to communicate without errors.
Term Type (TTY) Legend for This Page
The clinical cards above utilize specific Term Types (TTY) to define the granularity of the drug concept:
- PSN Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
- SCD Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
* Please review the full disclaimer at the bottom of this page.
